Cervical premalignant lesions and their management
PDF
Cite
Share
Request
Review
VOLUME: 15 ISSUE: 2
P: 109 - 121
June 2014

Cervical premalignant lesions and their management

J Turk Ger Gynecol Assoc 2014;15(2):109-121
1. Department Of Obstetrics And Gynecology, Bahçesehir University Faculty Of Medicine, Istanbul, Turkey
No information available.
No information available
Received Date: 17.10.2013
Accepted Date: 17.10.2013
PDF
Cite
Share
Request

ABSTRACT

Cervical cancer is the tenth most common cancer in women in developed countries that have national screening programs, while it is in the second line in underdeveloped countries. According to Ministry of Health registry data, cervical cancer is the eighth most common cancer among female cancers in Turkey. Today, the most effective screening for cervical cancer is to obtain smears from the cervix. Therefore, periodic screening programs are of great importance in identifying preinvasive lesions to prevent their progression to invasive cancer. Today, with the use of human papilloma virus (HPV) vaccine, screening programs have brought new insights into the prevention of cervical cancer. Management of preinvasive lesions has to be known by each obstetrics and gynecology specialist. Redundant procedures and treatments can be avoided by directing patients correctly at this step. Cancer phobia should not be created. Ablative or destructive treatments should not be done without histological diagnosis; hysterectomy, which has an equal risk of recurrence, should not be recommended.

Keywords:
Cervix, preinvasive lesions, management, human papilloma virus